Travel Nurses, Inc. ranks among highest-scoring businesses on Inc.’s list of best workplaces.
GERMANTOWN, TN / ACCESSWIRE / June 20, 2024 / Travel Nurses, Inc. has been named to Inc.’s annual Best Workplaces list. Prominently featured on Inc.com, the list is the result of a comprehensive measurement of American companies that have excelled in creating exceptional workplaces and company cultures, whether operating in a physical or a virtual facility.
After collecting data from thousands of submissions, Inc. selected 543 honorees this year. Each company that was nominated took part in an employee survey, conducted by Quantum Workplace, which included topics such as management effectiveness, perks, fostering employee growth, and overall company culture. The organization’s benefits were also audited to determine overall score and ranking.
Travel Nurses, Inc. is a leading healthcare staffing agency with more than 35 years in the industry. Their commitment to integrity and transparency is not only recognized by corporate staff in the survey, but it is also echoed by the company’s healthcare professionals in their reviews.
“We are so honored to be on Inc.’s list of the Best Workplaces for 2024. This recognition reflects our ongoing commitment to fostering a supportive and empowering workplace culture where our team members can thrive and flourish,” said Bryan Burnett, CEO of Travel Nurses, Inc.
“Each year, Inc.’s Best Workplaces program recognizes the very best in terms of companies that have fostered a truly amazing culture,” says Inc. editor-in-chief Mike Hofman. “We use hard metrics and data as well as qualitative measures for judging in order to find the very best – and we’re proud that the program is highly selective.”
Contact Information:
Anna Joy Tamayo
Community and PR Manager
annajoy@travelnursesinc.com
901-347-0271
Catherine Knoll
Vice President of Marketing
catherine.knoll@travelnursesinc.com
901-425-1636
Related Images
SOURCE: Travel Nurses, Inc.
View the original press release on newswire.com.
View the original press release on accesswire.com
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…
